Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bradykinin receptor B1 (B1R) is a G protein-coupled receptor (GPCR) that is induced primarily under pathological conditions, such as inflammation and tissue injury. It mediates inflammatory responses, cell migration, and contributes to chronic pain. Its activation increases cytosolic calcium ion concentration. It is a target for research into chronic pain management and anti-inflammatory therapies.
Agonist or antagonist binding to BDKRB1 to modulate downstream signaling pathways, primarily calcium signaling and inflammatory cascades.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bradykinin Receptor B1 (None).